Growing community of inventors

Zionsville, IN, United States of America

Jennifer Anne McMahon

Average Co-Inventor Count = 4.55

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 27

Jennifer Anne McMahonDaniel Jon Sall (3 patents)Jennifer Anne McMahonJolie Anne Bastian (3 patents)Jennifer Anne McMahonJeffrey Daniel Cohen (3 patents)Jennifer Anne McMahonAlmudena Rubio (3 patents)Jennifer Anne McMahonLeonard Larry Winneroski, Jr (1 patent)Jennifer Anne McMahonRussell Dean Stucky (1 patent)Jennifer Anne McMahonJose Eduardo Lopez (1 patent)Jennifer Anne McMahonErik James Hembre, Ii (1 patent)Jennifer Anne McMahonMiles Goodman Siegel (1 patent)Jennifer Anne McMahonTimothy Andrew Woods (1 patent)Jennifer Anne McMahonSimon James Richards (1 patent)Jennifer Anne McMahonJennifer Anne McMahon (5 patents)Daniel Jon SallDaniel Jon Sall (70 patents)Jolie Anne BastianJolie Anne Bastian (31 patents)Jeffrey Daniel CohenJeffrey Daniel Cohen (13 patents)Almudena RubioAlmudena Rubio (9 patents)Leonard Larry Winneroski, JrLeonard Larry Winneroski, Jr (39 patents)Russell Dean StuckyRussell Dean Stucky (23 patents)Jose Eduardo LopezJose Eduardo Lopez (16 patents)Erik James Hembre, IiErik James Hembre, Ii (15 patents)Miles Goodman SiegelMiles Goodman Siegel (11 patents)Timothy Andrew WoodsTimothy Andrew Woods (10 patents)Simon James RichardsSimon James Richards (5 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Eli Lilly and Company (5 from 4,447 patents)


5 patents:

1. 11993608 - Selective estrogen receptor degraders

2. 11634426 - Selective estrogen receptor degraders

3. 11117902 - Selective estrogen receptor degraders

4. 10336726 - 3-methyl-pyrrolidine-2,5-dione derivatives useful as CGRP receptor antagonists

5. 9522923 - Selective BACE1 inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/5/2026
Loading…